Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling

被引:0
|
作者
Wei Zheng [1 ,2 ]
Guo-Liang Shen [3 ]
Ke-Yang Xu [4 ]
Qiao-Qiao Yin [2 ]
Tian-Chen Hui [5 ]
Zhe-Wen Zhou [5 ]
Cheng-An Xu [6 ]
Shou-Hao Wang [7 ]
Wen-Hao Wu [7 ]
Ling-Fei Shi [8 ]
Hong-Ying Pan [2 ]
机构
[1] Department of Clinical Medicine, Medical College of Soochow University
[2] Department of Infectious Diseases, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College
[3] Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College
[4] School of Chinese Medicine, Hongkong Baptist university
[5] Department of Graduate School, Bengbu Medical College
[6] Second Clinical Medical College, Zhejiang Chinese Medical University
[7] Medical Department of Qingdao University, Qingdao University
[8] Diagnosis and Treatment Center of Osteoporosis, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College
关键词
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
BACKGROUND Liver cancer is one of the most highly malignant cancers, characterized by easy metastasis and chemoradiotherapy resistance. Emerging evidence indicates that long noncoding RNAs(Lnc RNAs), including Lnc524369, are highly involved in the initiation, progression, radioresistance, and chemoresistance of hepatocellular carcinoma(HCC). However, the function of Lnc524369 remains unclear.AIM To explore the function of Lnc524369 in HCC.METHODS To investigate the effect of Lnc524369, tissue from 41 HCC patients were analyzed using CCK8, migration, and invasion assays. Lnc524369 and YWHAZ(also named 14-3-3ζ) m RNA were detected by q PCR, and YWHAZ and RAF1 proteins were detected by western blot in liver cancer cell lines and human HCC tissues. The Cancer Cell Line Encyclopedia(CCLE) databases, STRING database, Human Protein Atlas database, and the TCGA database were used for bioinformatic analysis.RESULTS Lnc524369 was significantly upregulated in the nucleus of liver cancer cells and human HCC tissues. Overexpression of Lnc524369 was associated with the proliferation, migration, and invasion of liver cancer cells. YWHAZ and RAF1 proteins and YWHAZ m RNA were overexpressed in liver cancer, which could be attenuated by overexpression of Lnc524369. Lnc524369 and its downstream target YWHAZ and RAF1 proteins were negatively associated with overall survival time.CONCLUSION Lnc524369 might be a promising target of HCC as it can enhance liver cancer progression and decrease the overall survival time of HCC by activating the YWHAZ/RAF1 pathway.
引用
收藏
页码:253 / 264
页数:12
相关论文
共 50 条
  • [1] Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling
    Zheng, Wei
    Shen, Guo-Liang
    Xu, Ke-Yang
    Yin, Qiao-Qiao
    Hui, Tian-Chen
    Zhou, Zhe-Wen
    Xu, Cheng-An
    Wang, Shou-Hao
    Wu, Wen-Hao
    Shi, Ling-Fei
    Pan, Hong-Ying
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (01) : 253 - 264
  • [2] WDR1 predicts poor prognosis and promotes cancer progression in hepatocellular carcinoma
    Zheng, Linhui
    Hu, Fang
    Li, Jiaxi
    Wang, Zhiwen
    Deng, Li
    Xiao, Benping
    Li, Jianfeng
    Lei, Xiong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (12): : 5682 - 5693
  • [3] LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling
    Liu, Ji
    Xu, Rui
    Mai, Shi-Juan
    Ma, Yu-Shui
    Zhang, Mei-Yin
    Cao, Ping-Sheng
    Weng, Nuo-Qing
    Wang, Rui-Qi
    Cao, Di
    Wei, Wei
    Guo, Rong-Ping
    Zhang, Yao-Jun
    Xu, Li
    Chen, Min-Shan
    Zhang, Hui-Zhong
    Huang, Long
    Fu, Da
    Wang, Hui-Yun
    THERANOSTICS, 2020, 10 (17): : 7527 - 7544
  • [4] PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis
    Du, Peng
    Luo, Kaifeng
    Li, Guoyong
    Zhu, Jisheng
    Xiao, Qi
    Li, Yong
    Zhang, Xingjian
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (15): : 3588 - 3598
  • [5] NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
    Zhang, Xiao-Wen
    Wu, Lu-Yi
    Liu, Hui-Rong
    Huang, Yan
    Qi, Qin
    Zhong, Rui
    Zhu, Lu
    Gao, Chun-Fang
    Zhou, Lin
    Yu, Jian
    Wu, Huan-Gan
    ONCOLOGY LETTERS, 2022, 24 (06)
  • [6] Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis
    Cui, Yifeng
    Sun, Dan
    Song, Ruipeng
    Zhang, Shugeng
    Liu, Xirui
    Wang, Yan
    Meng, Fanzheng
    Lan, Yaliang
    Han, Jihua
    Pan, Shangha
    Liang, Shuhang
    Zhang, Bo
    Guo, Hongrui
    Liu, Yufeng
    Lu, Zhaoyang
    Liu, Lianxin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (12) : 22623 - 22634
  • [7] Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway
    Wang, Fu
    Xu, Wei-Qi
    Zhang, Wan-Qin
    Xu, Ru-Chen
    Sun, Jia-Lei
    Zhang, Guang-Cong
    Liu, Zhi-Yong
    Qi, Zhuo-Ran
    Dong, Ling
    Weng, Shu-Qiang
    Shen, Xi-Zhong
    Liu, Tao-Tao
    Fang, Ying
    Zhu, Ji-Min
    HEPATOLOGY INTERNATIONAL, 2024, 18 (02) : 636 - 650
  • [8] Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway
    Fu Wang
    Wei-Qi Xu
    Wan-Qin Zhang
    Ru-Chen Xu
    Jia-Lei Sun
    Guang-Cong Zhang
    Zhi-Yong Liu
    Zhuo-Ran Qi
    Ling Dong
    Shu-Qiang Weng
    Xi-Zhong Shen
    Tao-Tao Liu
    Ying Fang
    Ji-Min Zhu
    Hepatology International, 2024, 18 : 636 - 650
  • [9] RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma
    Liu, Tianze
    Li, Wenbin
    Lu, Wenjing
    Chen, Miao
    Luo, Meihua
    Zhang, Changlin
    Li, Yixin
    Qin, Ge
    Shi, Dingbo
    Xiao, Binyi
    Qiu, Huijuan
    Yu, Wendan
    Kang, Lan
    Kang, Tiebang
    Huang, Wenlin
    Yu, Xinfa
    Wu, Xiaojun
    Deng, Wuguo
    THERANOSTICS, 2017, 7 (12): : 3138 - 3154
  • [10] Low expression of LACTB promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma
    Xue, Chen
    He, Yuting
    Zhu, Weiwei
    Chen, Xiaolong
    Yu, Yan
    Hu, Qiuyue
    Chen, Jianan
    Liu, Liwen
    Ren, Fang
    Ren, Zhigang
    Cui, Guangying
    Sun, Ranran
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (12): : 4152 - 4162